Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and inconsistent tablet performance. When you face obstacles in tablet lubrication, you need a reliable, proven option to keep your project on track.

In this infographic from Gattefossé, you will learn how Compritol® 888 ATO, a trusted excipient for over 50 years, helps you navigate common tablet lubrication detours that derail solid dose development, including:

• API Incompatibility
• Inconsistent Dissolution
• Overblending Challenges
• Safety and Nitrosamine Concerns

Whether you’re developing products for adults or pediatrics, Compritol® 888 ATO provides the safety, compatibility, and reliability to ensure you achieve your formulation goals.

Ready to reach the finish line?

Click the button below to download the infographic and learn how Gattefossé helps you clear the path to a successful oral tablet formulation.